Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price upped by Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 20.29% from the company’s current […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $36.00 target price on the stock. Needham & Company LLC’s target price would indicate a potential upside of 9.12% from […]
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been assigned an average rating of “Buy” from the ten analysts that are covering the stock, Marketbeat.com reports. Ten equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have issued ratings on the stock […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received a consensus rating of “Buy” from the ten research firms that are covering the company, Marketbeat reports. Ten analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have issued a report on the stock in the last […]
Revolution Medicines (NASDAQ:RVMD) Price Target Increased to $42 00 by Analysts at Wedbush theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.